Pfizer Inc (PFE) — 10-Q Filings

All 10-Q filings from Pfizer Inc. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (7)

  • 10-Q Filing — May 5, 2026
  • Pfizer Q3 Revenue Dips 6% Amid R&D Surge, Net Income Down 21% — Nov 4, 2025 Risk: medium
    Pfizer Inc. reported a decrease in total revenues for the three months ended September 28, 2025, falling to $16.654 billion from $17.702 billion in the prior ye
  • Pfizer Q2 Revenue Dips 12% Amid Product Sales Decline — Aug 5, 2025 Risk: medium
    Pfizer Inc. reported product revenue of $12.5 billion for the second quarter of 2025, a decrease from $14.2 billion in the second quarter of 2024, representing
  • Pfizer Files Q1 2025 10-Q Report — May 5, 2025 Risk: low
    Pfizer Inc. filed its 10-Q for the period ending March 30, 2025. The filing details financial performance and operational updates for the first quarter of 2025.
  • Pfizer Files 10-Q for Q3 2024 — Nov 4, 2024 Risk: low
    Pfizer Inc. filed its 10-Q for the period ending September 29, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Key finan
  • Pfizer Inc. Files 10-Q for Q2 2024 — Aug 5, 2024 Risk: low
    Pfizer Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational segments for the second quarter and the
  • Pfizer Inc. Files 10-Q for Period Ending March 31, 2024 — May 8, 2024 Risk: low
    PFIZER INC (PFE) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Pfizer Inc. filed its quarterly report (10-Q) for the period ending March 31, 2024

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.